Skip to main content

Hemoglobinopathy clinical trials at UCSF

3 in progress, 2 open to eligible people

Hemoglobinopathy is a blood disorder. UCSF is studying how EDIT-301 can help people with severe sickle cell disease. Another trial is looking at how EDIT-301 can be used in stem cell transplants for Beta Thalassemia.

Showing trials for

Our lead scientists for Hemoglobinopathy research studies include .

Last updated: